Oncology Consortium

Impactful Education Through Innovative Engagement

roy.berger@theoncologyconsortium.com | (516) 729-0303

Paul A. Bunn, Jr., MD

Thoracic Oncology Consortium

Dr. Bunn’s studies have set standards for the treatment of lung cancer, have identified issues of natural history and have identified biomarkers of prognosis and therapy selection. Dr. Bunn is the principal investigator on numerous national and local therapeutic trials and is also the principal investigator for the SPORE grant in lung cancer that is designed to conduct lung cancer translational research and Principal Investigator for the Lung Cancer Mutation Consortium.

David Gandara, M.D.

Thoracic Oncology Consortium

David R. Gandara, MD, Professor of Medicine at the University of California at Davis (UC Davis) School of Medicine, is the Senior Advisor to the Director, and Director of the Thoracic Oncology Program at UC Davis Comprehensive Cancer Center. He is a diplomat of the American Board of Internal Medicine specializing in Medical Oncology.

Primo Lara, MD

Thoracic and Urologic Oncology Consortium

Dr. Lara is Professor of Medicine at the University of California Davis School of Medicine. He is also Associate Director for Translational Research and Co-Leader of the Cancer Therapeutics Program at the UC Davis Comprehensive Cancer Center, a National Cancer Institute-designated cancer center. His principal research interest is in the field of developmental therapeutics, particularly in thoracic and genitourinary malignancies.

Joan Schiller, M.D.

Thoracic Oncology Consortium

Dr. Joan Schiller is widely published and internationally recognized for her work in lung cancer clinical research. She is the Deputy Director of Simmons Comprehensive Cancer Center, holds the Andrea L. Simmons Distinguished Chair in Cancer Research, and is division director of Hematology/Oncology at the University of Texas-Southwestern Medical Center in Dallas, which ranks among the top academic medical centers in the world. Dr. Schiller is also the principal investigator on many Phase I, II and III investigator-initiated and national clinical trials for lung cancer. For ten years, she served as chairperson of the Thoracic Oncology Committee of the Eastern Co-operative Oncology Group.

Download Capability Slide

Oncology Consortium | All Rights Reserved 2012-2017
Back to Top